DSGN - DESIGN THERAPEUTICS INC
Healthcare · NASDAQ
Current Price
$5.17
-4.26% today
Intrinsic Value
N/A
-
Market Cap
$307.5M
+36.5% this quarter
Smart Money Holders
10
-
Net Quarterly Flow
10 net buyers
More buying
Smart Money Signals
BUYING
100%of smart money are accumulating
Momentum Score
80▲
Smart Money Conviction
0%low
Net Flow Signal
+10net buyers
Investor Activity
0$100M+ new
Crowding Score
21
Exit Risk
0%reducing
Recent Activity
REDUCEDQ2 2025
BlackRock, Inc
Reduced position by $1.5M (-15.7%)
UNDERWATER -68%
REDUCEDQ2 2025
Point72 Asset Management
Reduced position by $927K (-13.2%)
REDUCING
INVESTOR | LAST FILED | SHARES | % PORTFOLIO / VALUE | QUARTERLY ACTIVITY | HOLDING PERIOD | SIGNALS |
---|---|---|---|---|---|---|
Point72 Asset Management | 2025 Q2 | 1,807,218 | 0.01%$6.1M | -11K shares -$927K value | 2 years | REDUCING |
BlackRock, Inc | 2025 Q2 | 2,395,743 | 0.00%$8.1M | -84K shares -$1.5M value | 4 years | REDUCINGUNDERWATER -68%HIGH TURNOVER |
Vanguard Group | 2025 Q2 | 1,471,574 | 0.00%$5M | +44K shares -$551K value | 4 years | INCREASINGUNDERWATER -70%BUILDINGHIGH TURNOVER |
Citadel Advisors | 2025 Q2 | 840,793 | 0.00%$2.8M | -123K shares -$885K value | 4 years | REDUCINGUNDERWATER -27% |
D. E. Shaw & Co | 2025 Q2 | 390,648 | 0.00%$1.3M | -5K shares -$209K value | 2 years | REDUCINGUP +64% |
Renaissance Technologies | 2025 Q2 | 267,800 | 0.00%$902K | +3K shares -$120K value | 2 years | INCREASINGHOLDING +112%BUYS DIPSBUILDING |
Goldman Sachs | 2025 Q2 | 239,459 | 0.00%$807K | -27K shares -$220K value | 4 years | REDUCINGUNDERWATER -55%HIGH TURNOVER |
Two Sigma Investments | 2025 Q2 | 89,311 | 0.00%$301K | -39K shares -$196K value | 2.5 years | REDUCING |
AQR Capital Management | 2025 Q2 | 28,726 | 0.00%$97K | -3K shares -$26K value | 1.5 years | REDUCING |
JPMorgan Chase & Co | 2025 Q2 | 18,325 | 0.00%$62K | -952 shares -$13K value | 4 years | REDUCINGUNDERWATER -54%HIGH TURNOVER |
Smart Money Activity vs Price
TOTAL BUYS
$358.1M
TOTAL SELLS
$79.6M
NET FLOW
+$278.5M
PRICE CHANGE
-87.2%
PEAK ACTIVITY
2021 Q1